Titre : | Death associated with the use of the synthetic cannabinoid ADB-FUBINACA (2016) |
Auteurs : | K. G. SHANKS ; W. CLARK ; G. BEHONICK |
Type de document : | Article : Périodique |
Dans : | Journal of Analytical Toxicology (Vol.40, n°3, April 2016) |
Article en page(s) : | 236-239 |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés ETUDE DE CAS ; DROGUES DE SYNTHESE ; CANNABINOIDES ; MORTALITE ; THROMBOSE ; COEUR ; ANALYSE CHIMIQUE ; AUTOPSIE ; TOXICOLOGIE |
Résumé : | Synthetic cannabinoids have been found in herbal incense products for the last several years. We report the rapid death of an individual that was certified as synthetic cannabinoid-associated. The autopsy blood specimen was extracted by a liquid-liquid extraction at pH 10.2 into a hexane-ethyl acetate mixture and analyzed by a generalized synthetic cannabinoid LC-MS-MS method. For this case report, we briefly describe the instrumental analysis and extraction methods for the detection of ADB-FUBINACA in postmortem blood, toxicological results for the postmortem blood specimen (ADB-FUBINACA, 7.3 ng/mL; THC, 1.1 ng/mL; THC-COOH, 4.7 ng/mL), case information and circumstances and pertinent findings at autopsy. The cause of death was certified as coronary arterial thrombosis in combination with synthetic cannabinoid use. Manner of death was accident. |
Domaine : | Autres substances / Other substances |
Sous-type de document : | Etude de cas / Case report |
Refs biblio. : | 23 |
Affiliation : | AIT Laboratories, Indianapolis, IN, USA |
Accueil